On-Demand Webinar

From Dosimetry to Dose Decisions: How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Learn how dosimetry, clinical pharmacology, pharmacometrics, QSP, and regulatory strategy support dose optimization for therapeutic…

Hunter Stephens, PhDJuly 17, 2026

Publication

Population pharmacokinetic analysis and exposure–response analysis of brexpiprazole in Japanese patients with agitation in Alzheimer’s dementia

Explore how population pharmacokinetic and exposure–response modeling informed brexpiprazole dosing in Japanese patients with agitation…

CertaraJuly 16, 2026

On-Demand Webinar

Global Health Policy on the Move: Impact of MFN and EU HTA reform on Global and Regional Access

CertaraJuly 13, 2026

Blog

When to conduct hepatic impairment studies and when modeling may be enough

How to decide if a hepatic impairment study is required, choose the right study design,…

Zoe BarterJuly 13, 2026

Conference

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Matt Zierhut, PhD MBAJuly 9, 2026

Blog

Dosimetry for radiopharmaceutical therapy: From measurement to dose justification

Why dosimetry for radiopharmaceutical therapy needs more than absorbed dose. How BED, radiation dosimetry &…

Hunter Stephens, PhDJuly 7, 2026

Publication

Population PK Modeling Supporting the Aripiprazole Two-Injection Start Regimen in Japanese Patients

Learn how population PK modeling and simulation supported a regulatory strategy for a simplified aripiprazole…

Danielle PillsburyJuly 7, 2026

Blog

Enhancing clinical trials with real-world evidence in pregnancy research

Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…

Alekhya Lavu, PhD, PharmDJune 26, 2026

Guide

How to Build a Best Practice Global Value Dossier With a Decision-first Strategy

Learn how a decision-first approach to value dossier preparation helps teams build pharma value dossiers…

CertaraJune 25, 2026

Poster

Development of a human PBMC TXG-MAPr as a mechanistic framework to interpret toxicodynamic variability across the human population

Leiden University and EFSA researchers present the PBMC TXG-MAPr — a network-based transcriptomic tool mapping…

CertaraJune 23, 2026

Certara Services

From Dosimetry to Dose Decisions: How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Population pharmacokinetic analysis and exposure–response analysis of brexpiprazole in Japanese patients with agitation in Alzheimer’s dementia

Global Health Policy on the Move: Impact of MFN and EU HTA reform on Global and Regional Access

When to conduct hepatic impairment studies and when modeling may be enough

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Dosimetry for radiopharmaceutical therapy: From measurement to dose justification

Population PK Modeling Supporting the Aripiprazole Two-Injection Start Regimen in Japanese Patients

Enhancing clinical trials with real-world evidence in pregnancy research

How to Build a Best Practice Global Value Dossier With a Decision-first Strategy

Development of a human PBMC TXG-MAPr as a mechanistic framework to interpret toxicodynamic variability across the human population

Newsletter sign up

Quick links

Solutions

Contact